Rs 1,380 crore order book: 9 days ago, listed engineering company emerges as L1 bidder for an order worth Rs 152.91 crore from Chandigarh
The company's Class I (Super) Contractor certification enhances its eligibility for high-value projects, solidifying its position in the construction industry.
Deepak Builders & Engineers India Ltd (DBEIL) informed that the company has emerged as L1 bidder for Construction of 150 bedded Critical Care Block at PGIMER, Chandigarh and their Maintenance during Defect Liability Period on Comprehensive Design, Engineering, Procurement and Construction (EPC) basis with a bid project cost of Rs 152.91 crore. The duration for completion of the said project is 18 months.
Incorporated in 2017, Deepak Builders & Engineers India Ltd (DBEIL) is a construction company specializing in a diverse range of projects. Their core areas of expertise include administrative, institutional, and industrial buildings, hospitals, stadiums, residential complexes, and various infrastructure projects like flyovers, railway overbridges, and road networks. DBEIL primarily focuses on government-led projects, leveraging its EPC contracts and item-rate contracts to deliver turnkey solutions.
DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.
DBEIL's in-house design and engineering capabilities, coupled with their owned construction equipment, enable them to execute projects efficiently and reduce reliance on third-party contractors. Their strong presence in Northern India, particularly Punjab and Haryana, has been a significant contributor to their revenue. The company's Class I (Super) Contractor certification enhances its eligibility for high-value projects, solidifying its position in the construction industry.
The company has a market cap of over Rs 700 crore. As of June 30, 2024, DBEIL has an order book of Rs 1,380 crore with a focus on railway projects (66.03 per cent), industrial buildings (25.05 per cent), and hospital and medical projects (4.38 per cent). Investors should keep an eye in this small-cap stock.
Disclaimer: The article is for informational purposes only and not investment advice.